Madden Martin J. 4
4 · NovoCure Ltd · Filed Jun 10, 2022
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Madden Martin J.
Director
Transactions
- Award
Options to Buy Ordinary Shares
2022-06-08+8,700→ 8,700 totalExercise: $77.25Exp: 2032-06-08→ Ordinary Shares (8,700 underlying)
Footnotes (1)
- [F1]Options to buy 8,700 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2023 annual general meeting of shareholders.